Bausch Health Companies

Yahoo Finance • 4 days ago

Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals

Company Logo Oligometastatic Disease (OMD) is a cancer stage where the disease spreads to a limited number of sites, offering a better prognosis than widespread metastasis. The OMD market is experiencing growth, driven by advances in diag... Full story

Yahoo Finance • 7 days ago

Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth

Company Logo The cannabis pharmaceuticals market is poised for significant growth due to rising medical cannabis legalization, increasing R&D investment, and demand for alternative treatments. Key opportunities include advancements in can... Full story

Yahoo Finance • 25 days ago

Why Bausch Health Companies Was Crawling Higher This Week

Key Points There was notable growth on both the top and bottom lines. The two metrics also topped analyst estimates.10 stocks we like better than Bausch Health Companies › Earlier this week Bausch Health Companies(NYSE: BHC) delivered an... Full story

Yahoo Finance • 25 days ago

TSX up 455 Points at Midday With Healthcare, Materials, The Best Performers

The Toronto Stock Exchange is up 455 points at midday, partially recouping some of the 630 points lo PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 26 days ago

Bausch Health Q1 Adjusted Earnings, Revenue, Advance, Beating Estimates

Bausch Health (BHC.TO) up 3.6% in after-hours New York trade, after the company on Wednesday said it PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 26 days ago

BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS

First Quarter Consolidated Revenues of $2.52 billion, up 12% on a Reported basis and 7% on an Organic (non-GAAP)1 basis over the prior year period GAAP Net Loss Attributable to Bausch Health of $1,423 million and GAAP Net Loss of $1,431 mi... Full story

Yahoo Finance • 28 days ago

Bausch Health Companies Inc. (BHC): Billionaire Howard Marks Likes This Pharma Stock

We just covered the Billionaire Howard Marks’ 10 Stock Picks with Huge Upside Potential and Bausch Health Companies Inc. (NYSE:BHC) ranks 1st on this list. Bausch Health Companies Inc. (NYSE:BHC) has been a consistent feature in the 13F p... Full story

Yahoo Finance • 2 months ago

What Makes Bausch Health (BHC) Appear So Attractive

Bausch Health Companies Inc. (NYSE:BHC) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge funds. On February 25, Glen Santangelo from Barclays reduced the price target on Bausch Health Companies Inc. (NYSE... Full story

Yahoo Finance • 3 months ago

OTC Artificial Tears Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo The OTC Artificial Tears market is projected to expand from USD 4.93 billion in 2025 to USD 7.22 billion by 2033, growing at a CAGR of 4.88%. This growth is driven by increased accessibility in public spaces, rising dry eye s... Full story

Yahoo Finance • 3 months ago

Vision Care Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo The Vision Care market is expected to grow from US$81.23 billion in 2025 to US$117.75 billion by 2033, at a CAGR of 4.75%. Factors driving this growth include enhanced access to healthcare, increased awareness of eye health,... Full story

Yahoo Finance • 3 months ago

Bausch Health Companies Inc (BHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

This article first appeared on GuruFocus. Revenue: $2,796 million, up 9% on a reported basis year over year. Adjusted Gross Margin: 71.6%, a decrease of 80 basis points from the previous year. Adjusted Operating Expenses: $133 million, an... Full story

Yahoo Finance • 3 months ago

Earnings week ahead: WMT, ET. OXY, PANW, NEM, MDT, DVN, DE, ETSY, CVNA, and more

MicroStockHub/iStock via Getty Images Despite a holiday-shortened week, earnings season rolls on with another eventful slate ahead, as a diverse mix of consumer, energy, technology, healthcare, financial, and materials companies step into... Full story

Yahoo Finance • 5 months ago

Bausch Health Announces Final Results and Expiration of Exchange Offers

LAVAL, QC / ACCESS Newswire / December 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") and its subsidiary 1261229 B.C. Ltd. (the "Issuer" and, together with the Company, the "Offerors") today announced the final... Full story

Yahoo Finance • 6 months ago

Is There Now an Opportunity in Bausch Health Companies After Recent Debt Restructuring Developments?

Wondering whether Bausch Health Companies stock is a hidden gem or a value trap? You are not alone. This is a question investors need good answers to before taking the plunge. After soaring 15.4% in just the last week, but only eking out a... Full story

Yahoo Finance • 6 months ago

Stock Market Today: Nasdaq, S&P 500 Mount Midday Recovery As Market Returns From Holiday

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Monday. This is TheStreet’s Stock Market Today for Dec. 1, 2025. You can... Full story

Yahoo Finance • 6 months ago

TSX Down 140 Points at Midday With Info Tech The Worst Performer

The Toronto Stock Exchange, which was down 230 points in earlier trade, has recovered slightly and i PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 6 months ago

Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China

Transaction boosts Solta Medical's position to meet rising demand in China's growing aesthetics market LAVAL, QC / ACCESS Newswire / December 1, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical... Full story

Yahoo Finance • 6 months ago

Carl Icahn's top Q3 moves include new stake in EchoStar, exiting Bausch Health

[The New York Times 2015 DealBook Conference] Neilson Barnard Carl Icahn took a new stake in satellite communications provider EchoStar (SATS [https://seekingalpha.com/symbol/SATS]) in Q3 2025, while exiting his stake in Canadian pharmace... Full story

Yahoo Finance • 7 months ago

Jim Cramer reveals 5 'boneheaded mistakes' he's made over decades of investing — how you can avoid the costly errors

Robin Marchant/Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. Ask any celebrated investor the secrets to their success, and they’ll probably mention their setbacks too. Nob... Full story

Yahoo Finance • 7 months ago

Europe Photodynamic Therapy Market Size, Trends, Leading Applications and Pricing Benchmarks (2025-2033) Featuring Gladerma, Sun Pharmaceutical, Biofrontera, Lumibird, Bausch Health Companies and More

Company Logo European Photodynamic Therapy MarketEuropean Photodynamic Therapy Market Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Europe Photodynamic Therapy Market Size and Trends 2025-2033" has been added to ResearchAndMarkets.com'... Full story